RIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XV
RIVANNA announced on October 22, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for BoneEnhance, a machine learning software module for the company's Accuro XV diagnostic ultrasound system. The module segments bone and surrounding tissues and supports visualization of ske…
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-10-22 18:26 · Unite.AI
RIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XV